Adamis Pharmaceuticals Corp

NASDAQ:ADMP   3:56:30 PM EDT
0.46
+0.02 (+3.47%)
Products

Adamis Pharmaceuticals Issues Nationwide Voluntary Recall Of SYMJEPI Injection

Published: 03/21/2022 20:14 GMT
Adamis Pharmaceuticals Corp (ADMP) - Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of Symjepi® (epinephrine) Injection for Potential Manufacturing Defect.
Adamis Pharmaceuticals Corp - Voluntarily Recalling Certain Lots of Symjepi Injection Pre-filled Single-dose Syringes to Consumer Level.
Adamis Pharmaceuticals Corp - Batches Being Recalled Due to Potential Clogging of Needle Preventing Dispensing of Epinephrine.